United States · FDA National Drug Code directory
LACOSAMIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 31722-815_54d629b7-e234-69f1-e063-6294a90ab0e7
- Product NDC
- 31722-815
- Form
- TABLET, FILM COATED
- Composition / generic term
- LACOSAMIDE
- Labeler
- Camber Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220317
- Source listing expiry
- 20271231
Source-listed ingredients
- LACOSAMIDE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET, FILM COATED in 1 BOTTLE (31722-815-05) · 31722-815-05
- 180 TABLET, FILM COATED in 1 BOTTLE (31722-815-18) · 31722-815-18
- 100 TABLET, FILM COATED in 1 BLISTER PACK (31722-815-32) · 31722-815-32
- 60 TABLET, FILM COATED in 1 BOTTLE (31722-815-60) · 31722-815-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →